Suppression of recurrent transient ischemic attacks by a statin agent

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Recent studies of hydroxy-methylglutaryl coenzyme A reductase inhibitors have demonstrated that therapy with statins is associated with a significant decrease in the risk of stroke and TIA in patients with coronary artery disease. The underlying mechanism responsible for this effect is unclear. The author presents two patients who had cessation of TIAs upon institution of statin therapy. A variety of non-lipid-lowering mechanisms may account for this beneficial effect. This initial observation, if confirmed by further study, may suggest a role for statin agents in preventing recurrent TIAs.

Original languageEnglish (US)
Pages (from-to)531-532
Number of pages2
Issue number4
StatePublished - Feb 27 2001

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Suppression of recurrent transient ischemic attacks by a statin agent'. Together they form a unique fingerprint.

Cite this